Prevalence, drug-induced hepatotoxicity, and mortality among patients multi-infected with HIV, tuberculosis, and hepatitis virus

This publication has 19 references indexed in Scilit:

• Evolving epidemiology of hepatitis C virus
  Clinical Microbiology and Infection, 2011
• Epidemiological serosurvey of Hepatitis B in China—Declining HBV prevalence due to Hepatitis B vaccination
  Vaccine, 2009
• Interaction of Hepatitis B and C Viruses in Patients Infected With HIV
  JAIDS Journal of Acquired Immune Deficiency Syndromes, 2008
• Viral hepatitis and HIV-associated tuberculosis: Risk factors and TB treatment outcomes in Thailand
  BMC Public Health, 2008
• Short communication: Antituberculosis drug‐induced hepatotoxicity is unexpectedly low in HIV‐infected pulmonary tuberculosis patients in Malawi
  Tropical Medicine & International Health, 2007
• Treatment of Chronic Hepatitis B or C in HIV‐Infected Patients with Dual Viral Hepatitis
  The Journal of Infectious Diseases, 2007
• Hepatitis C Virus Infection and Hepatotoxicity During Antituberculosis Chemotherapy
  Chest, 2007
• Treatment of hepatitis B with lamivudine and tenofovir in HIV/HBV‐coinfected patients: factors associated with response
  Journal of Viral Hepatitis, 2006
• Inactive Hepatitis B Surface Antigen Carrier State and Hepatotoxicity During Antituberculosis Chemotherapy*
  Chest, 2005
• Incidence of Serious Side Effects from First-Line Antituberculosis Drugs among Patients Treated for Active Tuberculosis
  American Journal of Respiratory and Critical Care Medicine, 2003